Clinical pharmacology and therapeutics use of digitalis glycosides.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004074:Digitoxin / Q000627:therapeutic use; D004077:Digoxin / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D007700:Kinetics; D007799:Lanatosides / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D009206:Myocardium / Q000201:enzymology; D010138:Pacemaker, Artificial; D010672:Phenytoin / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013959:Thyroid Diseases / Q000378:metabolism
D004071:Digitalis Glycosides; D007799:Lanatosides; D010672:Phenytoin; D004077:Digoxin; D008012:Lidocaine; D011433:Propranolol; D004074:Digitoxin; D000251:Adenosine Triphosphatases; D011802:Quinidine; D011342:Procainamide; D011188:Potassium